L. F. Mota

L. F. Mota

Auto-generated profile, based on publicly available information

L. F. Mota

Instituto Federal do Norte de Minas Gerais, Brasil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Brazilian Journal of Biology
Verified
Journal Article
Open access
OCO. Cardoso-Filho
O. Cardoso-Filho
MAM. O. Andrade
M. O. Andrade
VCV. A. A. Cardoso
V. A. A. Cardoso
VRV. S. Rodrigues
V. S. Rodrigues
FGFRANCISCO SILVEIRA GUIMARAES
FRANCISCO SILVEIRA GUIMARAES
LML. F. Mota
L. F. Mota
Cannabidiol (CBD), a key cannabinoid found in Cannabis sativa, has garnered significant attention for its therapeutic potential, including antimicrobial, antipsychotic, and neuroprotective effects. This study conducted an in silico investigation to predict the pharmacokinetic and toxicological profile of CBD, using molecular modelling and computational simulations. The results revealed that CBD has favourable properties for oral bioavailability, including moderate molecular weight and compliance with Lipinski’s Rule of Five, although its high lipophilicity (LogP) could limit absorption. CBD demonstrated a high ability to cross the blood-brain barrier, making it promising for central nervous system therapies. Toxicological assessments showed CBD to be non-carcinogenic and non-toxic to the kidneys or respiratory system. However, potential reproductive toxicity and interactions with hormonal receptors highlight areas requiring further research. Environmentally, CBD is highly biodegradable, posing minimal risk to bees and crustaceans, though its moderate toxicity to fish warrants ongoing ecotoxicological monitoring. Overall, CBD shows promise as a therapeutic agent, but certain risks require further investigation.